Literature DB >> 10850552

GABA-transaminase antisense oligodeoxynucleotide modulates cocaine- and pentylenetetrazol-induced seizures in mice.

M S Abel1, N Kohli.   

Abstract

The mechanism of action of many anticonvulsive agents is to increase the function of the GABAergic system. Inhibition of GABA-Transaminase (GABA-T), the degradative enzyme for GABA, increases GABA levels in the brain. In this study, antisense oligodeoxynucleotides (ASO) targeted at the start codon region of GABA-Transaminase mRNA were used to modify seizure activity. Mice were treated, by intracerebroventricular injection, with antisense oligos or appropriate controls. At various times after treatment, the animals were challenged with cocaine (70 mg/kg, i.p.) and observed for seizure activity. At 15 hours after treatment, 1.152 and 1.44 nmol antisense oligo blocked cocaine-induced seizures. There was no effect of antisense oligo 8 or 36 hours after treatment. In addition, treatment with 7.2 nmol antisense oligo prevented pentylenetetrazol-induced seizures. These data demonstrate the modulation of seizure threshold using antisense oligodeoxynucleotides to GABA-T.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10850552     DOI: 10.1023/a:1020737125843

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  23 in total

1.  Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study.

Authors:  R Matilainen; A Pitkänen; T Ruutiainen; E Mervaala; H Sarlund; P Riekkinen
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910

2.  Modest reduction of benzodiazepine binding in rat brain in vivo induced by antisense oligonucleotide to GABAA receptor gamma 2 subunit subtype.

Authors:  J Karle; M Nielsen
Journal:  Eur J Pharmacol       Date:  1995-11-30       Impact factor: 4.432

3.  Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up.

Authors:  T R Browne; R H Mattson; J K Penry; D B Smith; D M Treiman; B J Wilder; E Ben-Menachem; M J Napoliello; K M Sherry; G K Szabo
Journal:  Neurology       Date:  1987-02       Impact factor: 9.910

Review 4.  Drug interactions at the GABA receptor-ionophore complex.

Authors:  R W Olsen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

5.  Differential changes in induced seizures after hippocampal treatment of rats with an antisense oligodeoxynucleotide to the GABA(A) receptor gamma2 subunit.

Authors:  J Karle; P Laudrup; F Sams-Dodd; J D Mikkelsen; M Nielsen
Journal:  Eur J Pharmacol       Date:  1997-12-11       Impact factor: 4.432

Review 6.  Pharmacology of vigabatrin.

Authors:  A Sabers; L Gram
Journal:  Pharmacol Toxicol       Date:  1992-04

7.  Treatment with an antisense oligodeoxynucleotide to the GABAA receptor gamma 2 subunit increases convulsive threshold for beta-CCM, a benzodiazepine "inverse agonist', in rats.

Authors:  T J Zhao; H C Rosenberg; T H Chiu
Journal:  Eur J Pharmacol       Date:  1996-06-13       Impact factor: 4.432

8.  In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats.

Authors:  R Zhang; Z Lu; X Zhang; H Zhao; R B Diasio; T Liu; Z Jiang; S Agrawal
Journal:  Clin Chem       Date:  1995-06       Impact factor: 8.327

9.  Intracerebral site of convulsant action of bicuculline.

Authors:  S Piredda; C R Lim; K Gale
Journal:  Life Sci       Date:  1985-04-01       Impact factor: 5.037

10.  Antisense inhibition of striatal GABAA receptor proteins decreases GABA-stimulated chloride uptake and increases cocaine sensitivity in rats.

Authors:  J Peris; B J Jung; A Resnick; P Walker; O Malakhova; Y Bokrand; D Wielbo
Journal:  Brain Res Mol Brain Res       Date:  1998-06-15
View more
  2 in total

1.  Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy
Journal:  Brain Sci       Date:  2013-11-15

2.  Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.

Authors:  Melanie M Hoefer; Ana B Sanchez; Ricky Maung; Cyrus M de Rozieres; Irene C Catalan; Cari C Dowling; Victoria E Thaney; Juan Piña-Crespo; Dongxian Zhang; Amanda J Roberts; Marcus Kaul
Journal:  Exp Neurol       Date:  2014-09-20       Impact factor: 5.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.